|
- Synaptic vesicles-inspired nanoparticle with spatiotemporally controlled release ability as “nanoguard” for synergistic treatment of synucleinopathies.
- Charge-switchable zwitterionic polycarboxybetaine particle as an intestinal permeation enhancer for efficient oral insulin delivery.
- Strategies and materials of “SMART”non-viral vectors: overcoming the barriers for brain gene therapy.
- Targeted exosome coating gene-chem nanocomplex as “nanoscavenger” for clearing α-synuclein and immune activation of Parkinson's disease.
- Switchable nanoparticle for programmed gene-chem delivery with enhanced neuronal recovery and CT imaging for neurodegenerative disease treatment.
- Positively charged polyprodrug amphiphiles with enhanced drug loading and reactive oxygen species-responsive release ability for traceable synergistic therapy.
- Traceable nanoparticles with spatiotemporally controlled release ability for synergistic glioblastoma multiforme treatment.
- Traceable nanoparticle delivery of small interfering RNA and retinoic acid with temporally release ability to control neural stem cell differentiation for Alzheimer's disease therapy.
- Microenvironment-responsive three-pronged approach breaking traditional chemotherapy to target cancer stem cells for synergistic inoperable large tumor therapy.
| |